X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Prostate Cancer Preview: ASCO 2017 Data Likely to Change Practice

The past 5 years ofASCO Annual Meeting prostate sections have seen a plethora of new drugs showing significant activity against this disease, and the past 2 years have demonstrated the benefit of considering a more aggressive line of therapy upfront in men with metastatic disease. This year we will learn the results of interesting trials looking at an alternative option for upfront treatment in men with metastatic disease, the length of androgen deprivation when used in conjunction with radiotherapy, and a potential new marker of disease response.

Read more.

source: Medscape